[go: up one dir, main page]

WO2009056811A3 - Médicaments - Google Patents

Médicaments Download PDF

Info

Publication number
WO2009056811A3
WO2009056811A3 PCT/GB2008/003643 GB2008003643W WO2009056811A3 WO 2009056811 A3 WO2009056811 A3 WO 2009056811A3 GB 2008003643 W GB2008003643 W GB 2008003643W WO 2009056811 A3 WO2009056811 A3 WO 2009056811A3
Authority
WO
WIPO (PCT)
Prior art keywords
receptor activity
dopamine receptor
tetrahydrobenzothiazole
derivatives
tetrahydrobenzothiazole derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/GB2008/003643
Other languages
English (en)
Other versions
WO2009056811A2 (fr
Inventor
Holger Stark
Jukka Matti Leppanen
Britta Caroline Sasse
Oliver Saur
Tim Kottke
Michael Peter Hill
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Motac Neuroscience Ltd
Original Assignee
Motac Neuroscience Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Motac Neuroscience Ltd filed Critical Motac Neuroscience Ltd
Publication of WO2009056811A2 publication Critical patent/WO2009056811A2/fr
Publication of WO2009056811A3 publication Critical patent/WO2009056811A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/82—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D293/00—Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms
    • C07D293/10—Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms condensed with carbocyclic rings or ring systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne un composé représenté par la formule (I), dans laquelle X, Y, R1 et R2 sont tels que définis dans la description, ces composés étant destinés à être utilisés pour le traitement d'états pathologiques caractérisés par un déséquilibre de l'activité des récepteurs dopaminergiques.
PCT/GB2008/003643 2007-10-31 2008-10-28 Médicaments Ceased WO2009056811A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0721333.3 2007-10-31
GBGB0721333.3A GB0721333D0 (en) 2007-10-31 2007-10-31 Medicaments

Publications (2)

Publication Number Publication Date
WO2009056811A2 WO2009056811A2 (fr) 2009-05-07
WO2009056811A3 true WO2009056811A3 (fr) 2009-10-15

Family

ID=38834565

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2008/003643 Ceased WO2009056811A2 (fr) 2007-10-31 2008-10-28 Médicaments

Country Status (2)

Country Link
GB (1) GB0721333D0 (fr)
WO (1) WO2009056811A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010025235A1 (fr) * 2008-08-29 2010-03-04 Regents Of The University Of Michigan Ligands sélectifs du récepteur dopaminergique 3 (d<sb>3</sb>) et procédés pour les utiliser
EP2446756B2 (fr) * 2010-10-29 2021-11-10 British American Tobacco (Investments) Limited Procédé et appareil permettant d'introduire des additifs dans des produits de tabac sans fumée

Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0186087A1 (fr) * 1984-12-22 1986-07-02 Dr. Karl Thomae GmbH Tétrahydro-benzothiazoles, leur procédé de préparation et leur utilisation comme intermédiaires ou médicaments
EP0251077A1 (fr) * 1986-06-21 1988-01-07 Boehringer Ingelheim Kg Tétrahydro-benzothiazoles, leur préparation et leur utilisation
WO1996028157A1 (fr) * 1995-03-14 1996-09-19 Laboratoires Jacques Logeais Compositions pharmaceutiques contenant de la l-etrabamine, leurs utilisations et leurs procedes de preparation
WO1997045403A1 (fr) * 1996-05-31 1997-12-04 Pharmacia & Upjohn Company Amines cycliques a substitution aryle utilisees comme ligands de la dopamine d3
US20050020645A1 (en) * 2001-06-20 2005-01-27 Daiichi Pharmaceutical Co., Ltd. Diamine derivatives
WO2005092871A2 (fr) * 2004-03-19 2005-10-06 Dipharma S.P.A. Intermediaires pour la preparation de pramipexole
US20060063704A1 (en) * 2003-04-11 2006-03-23 Dong Zheng X Somatostatin-dopamine chimeric analogs
WO2007022182A1 (fr) * 2005-08-15 2007-02-22 University Of Virginia Patent Foundation Neurorestauration avec du pramipexole r(+)
WO2008012010A1 (fr) * 2006-07-27 2008-01-31 Ucb Pharma, S.A. Oxazoles et thiazoles fusionnés en tant que ligands du récepteur histamine h3
WO2008086353A1 (fr) * 2007-01-08 2008-07-17 Zurawski Vincent R Jr Dérivés contenant du propargyle de tétrahydro-benzthiazoles et procédés de fabrication et d'utilisation de ceux-ci
WO2008086047A1 (fr) * 2007-01-03 2008-07-17 Boehringer Ingelheim International Gmbh Inhibiteurs de la rho kinase
WO2008128961A1 (fr) * 2007-04-20 2008-10-30 Glaxo Group Limited Composés

Patent Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0186087A1 (fr) * 1984-12-22 1986-07-02 Dr. Karl Thomae GmbH Tétrahydro-benzothiazoles, leur procédé de préparation et leur utilisation comme intermédiaires ou médicaments
EP0251077A1 (fr) * 1986-06-21 1988-01-07 Boehringer Ingelheim Kg Tétrahydro-benzothiazoles, leur préparation et leur utilisation
WO1996028157A1 (fr) * 1995-03-14 1996-09-19 Laboratoires Jacques Logeais Compositions pharmaceutiques contenant de la l-etrabamine, leurs utilisations et leurs procedes de preparation
WO1997045403A1 (fr) * 1996-05-31 1997-12-04 Pharmacia & Upjohn Company Amines cycliques a substitution aryle utilisees comme ligands de la dopamine d3
US20050020645A1 (en) * 2001-06-20 2005-01-27 Daiichi Pharmaceutical Co., Ltd. Diamine derivatives
US20060063704A1 (en) * 2003-04-11 2006-03-23 Dong Zheng X Somatostatin-dopamine chimeric analogs
WO2005092871A2 (fr) * 2004-03-19 2005-10-06 Dipharma S.P.A. Intermediaires pour la preparation de pramipexole
WO2007022182A1 (fr) * 2005-08-15 2007-02-22 University Of Virginia Patent Foundation Neurorestauration avec du pramipexole r(+)
WO2008012010A1 (fr) * 2006-07-27 2008-01-31 Ucb Pharma, S.A. Oxazoles et thiazoles fusionnés en tant que ligands du récepteur histamine h3
WO2008086047A1 (fr) * 2007-01-03 2008-07-17 Boehringer Ingelheim International Gmbh Inhibiteurs de la rho kinase
WO2008086353A1 (fr) * 2007-01-08 2008-07-17 Zurawski Vincent R Jr Dérivés contenant du propargyle de tétrahydro-benzthiazoles et procédés de fabrication et d'utilisation de ceux-ci
WO2008128961A1 (fr) * 2007-04-20 2008-10-30 Glaxo Group Limited Composés

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
MAILLARD J ET AL: "SYNTHESE DE DERIVES AMINES DU TETRAHYDRO-4,5,6,7 BENZOTHIAZOLE I. ÖAMINES ET N-METHYLAMINES EN POSITIONS 4,5,6 ET 7 A ACTIVITE DOPAMINERGIQUE CENTRALE", EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, EDITIONS SCIENTIFIQUE ELSEVIER, PARIS, FR, vol. 19, no. 5, 1 January 1984 (1984-01-01), pages 451 - 456, XP000578112, ISSN: 0223-5234 *

Also Published As

Publication number Publication date
WO2009056811A2 (fr) 2009-05-07
GB0721333D0 (en) 2007-12-12

Similar Documents

Publication Publication Date Title
WO2010093849A3 (fr) Dérivés de la phénylalanine-amide utiles pour le traitement de maladies et états liés à l&#39;insuline
WO2009051244A1 (fr) Composé hétérocyclique
WO2009001060A3 (fr) Utilisation de composés pour la préparation d&#39;agents anti-tuberculose
MX2009004766A (es) Derivados de espiroindolinona.
MX2009012345A (es) Derivados de 3,3-espiroindolinona.
WO2011113798A3 (fr) Nouveaux composés d&#39;inhibiteurs enzymatiques
MX2010004435A (es) Compuestos espiro y uso farmaceutico de los mismos.
WO2008131860A3 (fr) Pyridone-carboxamides, phytoprotecteurs contenant ces composés, procédés pour leur production et leur utilisation
WO2008113559A3 (fr) Indolizines et dérivés analogues aza de celles-ci en tant que composés actifs sur le système nerveux central
TW200730486A (en) Organic sulfur compounds and use thereof
MX2008011723A (es) Derivado de triazol o su sal.
WO2008123469A1 (fr) Composé amide à six chaînons et son utilisation
TN2010000101A1 (en) Fungicidal 2-alkylthio-2-quinolinyloxy -acetamide derivatives
WO2009019015A8 (fr) Nouveaux herbicides
WO2007101864A3 (fr) Nouveaux composés, leur préparation et utilisation
MX2011008176A (es) Derivados de 3,3&#39;-espiroindolinona como agentes anticancerigenos.
EP2639229A3 (fr) Dérivé de thiazole et son utilisation en tant qu&#39;inhibiteur VAP-1
ZA201002206B (en) Pyridin-2-ty-amino-i,2,4-thiadiazole derivatives as glucokinase activators for the treatment of diabetes mellitus
ZA201002701B (en) Spiro-condensed 1,3,4-thiadiazole derivatives for inhibiting ksp kinesin activity
WO2007099171A3 (fr) Bicyclopyrazoles actifs comme inhibiteurs de la kinase
WO2009038412A3 (fr) Composés inhibiteurs de la béta-sécrétase
WO2009051223A1 (fr) Composition pharmaceutique pour le traitement de la cataracte
MY145451A (en) Ester compound and its use
MY146597A (en) Organic sulfur compound and its use for controlling harmful arthropods
WO2011042473A3 (fr) Nouveaux ligands des récepteurs des oestrogènes

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08845729

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08845729

Country of ref document: EP

Kind code of ref document: A2